Search research articles
Contact Us
Filters
Showing results (161-170 of 237) with videos related to
Page
of 24
Sort By:
Ophthalmology
|
February 6, 2018
Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration
Laura Lorés-Motta, Constantin C Paun, Jordi Corominas, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
December 1, 2018
Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
Danial Mohabati, Elon Hc van Dijk, Thomas J van Rijssen, et al.
Plos One
|
June 4, 2016
Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration
Nicole T M Saksens, Yara T E Lechanteur, Sanne K Verbakel, et al.
Plos One
|
June 21, 2019
Metabolomics in serum of patients with non-advanced age-related macular degeneration reveals aberrations in the glutamine pathway
Eveline Kersten, Sascha Dammeier, Soufiane Ajana, et al.
Pharmacogenetics and Genomics
|
October 2, 2015
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
Laura Lorés-Motta, Freekje van Asten, Philipp S Muether, et al.
JAMA Ophthalmology
|
April 9, 2026
Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial
Sumit Sharma, Phoebe Lin, Allen Hu, et al.
Ophthalmic Epidemiology
|
August 27, 2014
Predicting non-response to ranibizumab in patients with neovascular age-related macular degeneration
Freekje van Asten, Maroeska M Rovers, Yara T E Lechanteur, et al.
Translational Vision Science & Technology
|
September 4, 2020
Tear Proteomic Predictive Biomarker Model for Ocular Graft Versus Host Disease Classification
Olivia E O'Leary, Andreas Schoetzau, Ludovic Amruthalingam, et al.
Translational Vision Science & Technology
|
June 24, 2024
Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases
Björn Titz, Juliane Siebourg-Polster, Francois Bartolo, et al.
The British Journal of Ophthalmology
|
July 14, 2018
Discrepancy in current central serous chorioretinopathy classification
Sumit Randhir Singh, Alexandre Matet, Elon H C van Dijk, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 237) with videos related to
Sort By:
Page
of 24
Ophthalmology
|
February 6, 2018
Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration
Laura Lorés-Motta, Constantin C Paun, Jordi Corominas, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
December 1, 2018
Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
Danial Mohabati, Elon Hc van Dijk, Thomas J van Rijssen, et al.
Plos One
|
June 4, 2016
Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration
Nicole T M Saksens, Yara T E Lechanteur, Sanne K Verbakel, et al.
Plos One
|
June 21, 2019
Metabolomics in serum of patients with non-advanced age-related macular degeneration reveals aberrations in the glutamine pathway
Eveline Kersten, Sascha Dammeier, Soufiane Ajana, et al.
Pharmacogenetics and Genomics
|
October 2, 2015
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
Laura Lorés-Motta, Freekje van Asten, Philipp S Muether, et al.
JAMA Ophthalmology
|
April 9, 2026
Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial
Sumit Sharma, Phoebe Lin, Allen Hu, et al.
Ophthalmic Epidemiology
|
August 27, 2014
Predicting non-response to ranibizumab in patients with neovascular age-related macular degeneration
Freekje van Asten, Maroeska M Rovers, Yara T E Lechanteur, et al.
Translational Vision Science & Technology
|
September 4, 2020
Tear Proteomic Predictive Biomarker Model for Ocular Graft Versus Host Disease Classification
Olivia E O'Leary, Andreas Schoetzau, Ludovic Amruthalingam, et al.
Translational Vision Science & Technology
|
June 24, 2024
Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases
Björn Titz, Juliane Siebourg-Polster, Francois Bartolo, et al.
The British Journal of Ophthalmology
|
July 14, 2018
Discrepancy in current central serous chorioretinopathy classification
Sumit Randhir Singh, Alexandre Matet, Elon H C van Dijk, et al.
Page
of 24